CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with … – GlobeNewswire (press release)
Endpoints News |
CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with …
GlobeNewswire (press release) BASEL, Switzerland and CAMBRIDGE, Mass. and DURHAM, N.C., April 17, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases … CRISPR Therapeutics, Casebia ink AAV deal with StrideBio; Puma gets an AdComm date; Merrimack names new R&D … Chardan Capital Initiates Coverage on Crispr Therapeutics AG … Crispr Therapeutics AG (CRSP) Given Consensus Recommendation of "Strong Buy" by Analysts |
